MedTrace Logo

Targeted Screening for Taenia Solium Tapeworms

NCT01296958 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1811

Last updated 2014-10-24

No results posted yet for this study

Summary

The purpose of this study is to determine whether screening and treatment of tapeworm carriers can decrease community transmission of Taenia solium parasitic infection.

Conditions

  • Taenia Solium Taeniasis

Interventions

DRUG

Niclosamide

Single oral dose of niclosamide determined by weight (dose: 11 to 34kg receive 1 gram, 35 to 50kg receive 1.5 grams, over 50kg receive 2 grams)

BEHAVIORAL

Community education campaign

Education about prevention of Taenia solium infection provided in a single short (20 minute) interaction with the participant. Education was verbal with visual aids.

Sponsors & Collaborators

  • National University of San Marcos, Peru

    collaborator OTHER

  • National Institute of Neurological Disorders and Stroke (NINDS)

    collaborator NIH

  • Oregon Health and Science University

    lead OTHER

Principal Investigators

  • Seth E ONeal, MD MPH · Oregon Health and Science University

  • Armando Gonzalez, DVM PhD · San Marcos University School of Veterinary Medicine

Study Design

Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2013-01-31
Completion
2013-01-31

Countries

  • Peru

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01296958 on ClinicalTrials.gov